AstraZeneca jab risk-benefit ‘still largely positive’: WHO
With a big if, EU hopes for ‘community immunity’ by June
6 April 2021Small cell lung cancer: Scientists identify two new approaches for therapy
6 April 2021AstraZeneca jab risk-benefit ‘still largely positive’: WHO
The risk-benefit balance for the AstraZeneca COVID-19 vaccine is “still largely positive”, the World Health Organization said Tuesday after fresh claims about links to blood clots.
